Description
Dosage
Composition
Literature
FAQ
Reviews
A veterinary preparation, which is a source of EPA (eicosapentaenoic) and DHA (docosahexaenoic) acids, belonging to the Omega-3 family and a strong antioxidant – Astaxanthin. The product is recommended as an element of diet therapy in cases of: kidney and liver failure, heart diseases, neurodegenerative changes, inflammation of the joints and spine. It helps in the treatment of skin diseases with itching: seborrhea, atopy and relieves allergic reactions. The product is recommended for prophylactic use in puppies and adult dogs, especially dogs with high activity, breeding dogs, dogs with reduced immunity and tendency to allergies.
EPA and DHA fatty acids
Essential unsaturated fatty acids from the omega-3 family have a multifaceted, positive effect on the body of dogs and other domestic animals. EPA (eicosapentaenoic) and DHA (docosahexaenoic) acids play an important role in preventing and alleviating pathological changes, including inflammatory diseases [1].
They are an important element of diet therapy for animals with skin diseases and joint degeneration and inflammation on this background [2,3,4]. They have a positive effect on the functioning of the heart and nervous system [5,6].
EPA and DHA acids are also used in the diet therapy of kidney and liver failure in dogs [7].
A deficiency of EPA and DHA acids can increase the body’s susceptibility to infections. Studies conducted on dogs of different ages have shown that enriching the diet with unsaturated fatty acids from the omega-3 family has a positive effect on the functioning of the immune system [8].
In krill oil, EPA and DHA fatty acids are present in the form of phospholipids, which makes them more bioavailable than other sources.
Phospholipids
They have many functions and applications in the body. They are a structural element of cell membranes and a source of choline for the neurotransmitter acetylcholine, an important factor in the production and storage of energy, and also support blood clotting [9].
Phospholipids are particularly important for the liver, because hepatocyte membranes are composed of 65% phospholipids. They inhibit fibrosis processes in the liver, support its regeneration, and also participate in the digestion of fats and the absorption of vitamins dissolved in them [10].
A diet rich in phospholipids reduces liver fat by inhibiting the absorption of fat in the intestines and influencing the activity of liver enzymes that regulate lipid metabolism [11,12].
Phospholipids also play a key role in the functioning of the brain, because they constitute about 60% of the mass of this organ [13].
Astaxanthin
A strong antioxidant with a number of health-promoting properties. It neutralizes toxins and binds free radicals that damage body cells [14]. Astaxanthin accumulates in muscles, where it reduces the effects of oxidative stress and post-workout muscle damage [15]. By limiting the synthesis of pro-inflammatory biomarkers (e.g. interleukins), it alleviates inflammation in the body and accelerates tissue regeneration. It supports the proper functioning of the visual system [14].
Astaxanthin supports the proper functioning of the immune system: it strengthens both the cellular and humoral response (related to the functioning of the immune system). It increases the production of lymphocytes [16].
Products containing astaxanthin are recommended as an element of diabetes diet therapy, due to its ability to regulate blood glucose levels and increase insulin sensitivity [17,18].
Astaxanthin also has anti-cancer effects [16].
Available packages: 60 capsules
Degeneration of joints and spine
Kidneys
Skin
Brain
Heart
Dosage
Krill Oil
| 10 kg | 1 capsule | |
| 20 kg | 2 capsules | |
| 30 kg | 3 capsules |
It is recommended to use for at least 2 months.
For diagnosed chronic diseases, the target dosage and duration of supplementation should be consulted with a veterinarian.
Active substances
in 1 capsule
EPA
100 mg
DHA
60 mg
Phospholipids
200 mg
Astaxanthin
100 µg
Composition
Euphausia superba krill oil
Capsule shell composition
gelatin, glycerol
Analytical constituents
- protein 0%
- crude oil and fats 99%
- crude fibre 0%
- crude ash 0%
- Yashodhara B.M., Umakanth S., Pappachan J.M., BhatS.K., Karnath R., Choo B.H.: Omega-3 fatty acids: acomprehensive review of their role in health and disease. Postgrad. Med. J. 2009, 85, 84-90
- Abba , Mussa P., VercelliA., Raviti G.: Essential fatty acids supplementation in different-stage atopicdogs fed on controlled diet. JAnim PhysiolAnim Nutr (Berl) 2005, 89, 2003-2007.
- Scott D.W., MillerW.H. Jr., Reinhart G.A., Mohammed H.O., Bagladi M.S.: Effect of an omega-3/omega-6 fatty acid-containing commercial lamb and rice diet on pruritus in atopicdogs: results of a single-blindedstudy. Can. J. Vet. Res. 1997, 61, 145-153.
- Fritsch D.A., Allen T.A., Dodd C.E., Jewell D.E., Sixby K.A., Leventhal P.S., Brejda J., Hahn K.A.: A ulticenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. J Am Vet Med. Assoc., 2010, 236 (5), 535-539.
- Laurent G., Moe G., Hu X., Holub B., Leong-Poi H., Trogadis J., Conelly K., Courtman D., Strauss B.H., Dorian P.: Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in novel canine pacing model. Cardiovasc Res. 2008, 77, 89-97
- Smith C.E., Freeman L. M., Rush E.J., Cunnigham M.S., Eiourge V.: Omega-4 fatty acids in Boxer dogs with arrythmogenic right ventricular cadiomyopathy. J Vet Intern Med., 2007.21(2), 265-73.
- Brown S.A., Brown C.A., Crowell W.A., Barsanti J.A., Allen T., Cowell C., Finco D.R.:Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal J Lab Clin Med. 1998, 131(5), 447-55
- Kearns R.J., Hayek M.G., Turek J.J., Meydani M., Burr J.R., Greene R.J., Marshall C.A., Adams S.M., Borgert R.C., Reinhart G.A.: Effect of age, breed and dietary omega-6 (n-6): omega- 3 (n-3) fatty acid ratio on immune function, eicosanoid production, and lipid peroxidation in young and aged dogs. Vet. lmmunol. lmmunopathol. 1999, 69, 165-183.
- Kuellenberg, D., Taylor, L.A., Schneider, M., Massing, U. Health effects of dietary phospholipids. Lipids in health and disease. 2012, 11, 3.
- Gundermann K.J., Gundermann S., Drozdzik M., Prasad V.G. 2016. Essential phospholipids in fatty liver: a scientific update. Clinical and Experimental Gastroenterology. 9. 105. 10.2147/CEG.S96362.
- Welsh J.A., Karpen S., Vos M.B. Increasing prevalence of nonalcoholic fatty liver disease among united states adolescents, 1988-1994 to 2007-2010. The Journal of pediatrics, 2013,162, 496-500.
- Leite N.C., Salles G.F., Araujo A.L., Ville-la-Nogueira C.A., Cardoso C.R. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009, 29, 113-119
- Carter J.M., Demizieux L., Campenot R.B., Vance D.E., Vance J.E. Phosphatidylcholine biosynthesis via ctp:Phosphocholine cytidylyltransferase 2 facilitates neurite outgrowth and branching. J Biol Chem 2008, 283, 202-212.
- S. Fakhri, I. Y. Aneva, M. H. Farzaei, The Neuroprotective Effects of Astaxanthin: Therapeutic Targets and Clinical Perspective, „Molecules”, nr 24 2019.
- Wong SK, Ima-Nirwana S, Chin KY. Effects of astaxanthin on the protection of muscle health (Review). Exp Ther Med. 2020 Oct;20(4):2941-2952. doi: 10.3892/etm.2020.9075. Epub 2020 Jul 29. PMID: 32855659; PMCID: PMC7444411.
- Park J., Chyun J., Kim Y., Line L., Chew B. 2010. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutrition & metabolism. 7. 18. 10.1186/1743-7075-7-18.
- Medoro A., Intrieri M., Passarella D., Willcox D.C., Davinelli S., Scapagnini G. 2024. Astaxanthin as a metabolic regulator of glucose and lipid homeostasis. Journal of Functional Foods, Volume 112, 105937, ISSN 1756-4646, https://doi.org/10.1016/j.jff.2023.105937.
- Landon, R.; Gueguen, V.; Petite, H.; Letourneur, D.; Pavon-Djavid, G.; Anagnostou, F. Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications. Mar. Drugs 2020, 18, 357. https://doi.org/10.3390/md18070357.
Fish oil or krill oil?
Both are given to supplement the diet with unsaturated omega-3 fatty acids, which dogs cannot synthesize on their own. Fish oil, standardized to a high content of EPA and DHA acids, is an easily accessible source of fatty acids.
Krill oil, in addition to the beneficial EPA and DHA acids, also contains astaxanthin, which is responsible for cleansing the body of free radicals, as well as phospholipids, which have the ability to regenerate the liver. Both of these products are worth using as part of diet therapy in the case of diseases of the internal organs, skin or musculoskeletal system. For economic reasons, fish oil will be more affordable. It is worth remembering, however, that krill oil is characterized by higher bioavailability. These products can also be used interchangeably.
Aren't krill an endangered animal?
The Red List of Threatened Species published by the International Union for Conservation of Nature (IUCN) classifies the Arctic Krill Euphausia superba as a species of “Least Concern”, meaning that the species is not threatened with extinction.
Can this product be used in patients with pancreatic disease or in obese dogs?
This oil can be used in patients with a diseased pancreas, because our oils contain a high concentration of EPA and DHA acids in a small volume of oil, so they will not be dietary significant in terms of the overall fat content in the diet.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.